Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

John Daula

Psychiatry Boca Raton, FL Medical Doctor

NPI 1225359789 CMS profile 426796

9980 Central Park Blvd N Ste 210, Boca Raton, FL 33428

Open in the dashboard

General payments

$4,778

202 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Daula of Boca Raton, FL is reported in the CMS Open Payments database as having received $4,778 across 202 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,372 101
2024 General $1,967 82
2023 General $439 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Daula
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to John Daula were reported at $2,372. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year John Daula Psychiatry median Middle half National median
2019 $0 $184 $59–$605 $163
2020 $0 $119 $36–$372 $114
2021 $0 $143 $43–$576 $132
2022 $0 $153 $50–$590 $149
2023 $439 $170 $56–$651 $160
2024 $1,967 $179 $57–$673 $164
2025 $2,372 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Janssen Pharmaceuticals, Inc $550 16 payments
  2. AbbVie, Inc. $446 22 payments
  3. Lundbeck LLC $433 17 payments
  4. Axsome Therapeutics, Inc. $431 14 payments
  5. Neurocrine Biosciences, Inc. $387 9 payments
  6. Otsuka America Pharmaceutical, Inc. $335 17 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $333 15 payments
  8. Almatica Pharma LLC $304 16 payments
  9. Alkermes, Inc. $298 16 payments
  10. Teva Pharmaceuticals USA, Inc. $257 10 payments
  11. Other $1,003 50 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $4,774 201 payments
  2. Education $4 1 payment
Products named General payments · program years 2023–2025
  1. SPRAVATO $624 18 payments
  2. REXULTI Psychiatry $433 17 payments
  3. Auvelity $431 14 payments
  4. INGREZZA $387 9 payments
  5. TRINTELLIX $333 15 payments
  6. LOREEV XR $304 16 payments
  7. LYBALVI $298 16 payments
  8. REXULTI Psychiatry $293 14 payments
  9. Austedo XR $257 10 payments
  10. Azstarys $251 16 payments
  11. Other $2,198 114 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

644

Median for Psychiatry: 574

Drug cost

$46,932

Median for Psychiatry: $27,624

Branded share of claims

9.3%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Rexulti Brexpiprazole Brand 14 $28,575
Trintellix Vortioxetine Hydrobromide Brand 15 $9,845
Fluoxetine Hcl Generic 48 $1,632
Escitalopram Oxalate Generic 63 $1,023
Duloxetine Hcl Generic 45 $832
Mirtazapine Generic 47 $699
Alprazolam Generic 82 $536
Bupropion Xl Bupropion Hcl Brand 31 $524
Trazodone Hcl Generic 24 $471
Lamotrigine Generic 25 $419

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$62,585

Medicare's payments for the services billed

Medicare patients

100

Average age 72

Services billed

789

55 women, 45 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 75%
Arthritis 48%
Ischemic heart disease 45%
Diabetes 34%
Chronic kidney disease 24%
Cancer 22%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 21 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
REXULTI
  • Otsuka America Pharmaceutical, Inc. $221
  • Lundbeck LLC $177
$398 14 —
SPRAVATO
  • Janssen Pharmaceuticals, Inc $271
$271 — —
INGREZZA
  • Neurocrine Biosciences, Inc. $257
$257 — —
VRAYLAR
  • AbbVie, Inc. $213
$213 — —
LOREEV XR
  • Almatica Pharma LLC $147
$147 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 21 in the dashboard with a free account

Records

202 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record